Equity Capital Markets

Company · CIK 1722890

Taiwan Liposome Company, Ltd.

CIK1722890 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inF5
Business addressTaiwan
Listedno ticker on SEC record today
First annual or quarterly report2019-04-30

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-223090
IPOFinal prospectus
 2018-02-162018-11-268

Filings

10
FiledFilingRegistrationAccession
2018-11-26424B4Final prospectus 333-2230900001193125-18-334047
2018-11-20EFFECTDeclared effective 333-2233039999999995-18-002937
2018-11-20EFFECTDeclared effective 333-2230909999999995-18-002936
2018-11-14F-1/AAmendment 333-2230900001193125-18-326059
2018-11-08F-1/AAmendment 333-2230900001193125-18-322726
2018-10-22F-1/AAmendment 333-2230900001193125-18-304017
2018-09-17F-1/AAmendment 333-2230900001193125-18-274612
2018-04-16F-1/AAmendment 333-2230900001193125-18-117673
2018-02-16F-1Registration filed 333-2230900001193125-18-048760
2017-12-08DRSDraft made public 377-018250000950123-17-011287

All filings of this company · CSV